ascopubs.org

Single cell characterization of persistent cells upon immunotherapy treatment in colorectal and endometrial tumors: The SERPENTINE trial.

The pathway alteration load as a pan-cancer determinant of outcome of targeted therapies: Results from the Drug Rediscovery Protocol (DRUP). This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...
GEN

Label-Free Cell Analysis with Laser Force Cytology

The overall process for developing and manufacturing vaccines and cell and gene therapies (CGTs) is challenging and resource intensive because it involves complex and variable raw materials, demanding ...
Business Wire

Accellix Platform Chosen by the American Red Cross for Rapid and Accurate Allogeneic Source Material Characterization for Cell Therapy Development

SAN JOSE, Calif. & WASHINGTON--(BUSINESS WIRE)--The American Red Cross Cell and Gene Therapy Solutions (CGTS) division, a leading single-source provider for allogeneic cell therapy source material, ...
Business Wire

iXCells Biotechnologies Launches iPSCore Platform for Generating Highly Characterized iPSC-derived Human Cell Models

iXCells’ mission is to empower life science researchers and patient foundations to advance personalized therapies and accelerate discovery of better medicines for a healthier future. iXCells’ cell ...
Labroots

Make better decisions for cell therapy manufacturing: Leveraging image-enhanced flow cytometry for predictive donor material characterization

Rapid developments in gene-modified cell therapies, especially CAR T-cell therapies, has increased demand for fast and reliable analytics methods for research, in-process development, and ...